Outcomes After Endovascular Aortic Intervention in Patients With Connective Tissue Disease

医学 主动脉弓 外科 马凡氏综合征 人口统计学的 主动脉 回顾性队列研究 结缔组织病 内科学 疾病 社会学 人口学 自身免疫性疾病
作者
Kerstin Olsson,Kevin Mani,Anne Burdess,Suzannah Patterson,Salvatore T. Scali,Tilo Kölbel,Giuseppe Panuccio,Ahmed Eleshra,Luca Bertoglio,Vincenzo Ardita,Germano Melissano,Amish Acharya,Colin Bicknell,Celia Riga,Richard Gibbs,Michael Jenkins,Arvind Bakthavatsalam,Matthew P. Sweet,Piotr Kasprzak,Karin Pfister,Kyriakos Oikonomou,Héloïse Tessely,Jonathan Sobocinski,Talha Butt,Nuno Dias,Chun-Lei Tang,Stephen W.K. Cheng,Sarah Vandenhaute,Isabelle Van Herzeele,Rebecca Sorber,James H. Black,Emanuel R. Tenorio,Gustavo S. Oderich,Zoë Vincent,Manar Khashram,Matthew J. Eagleton,Steen Pedersen,Jacob Budtz-Lilly,Chiara Lomazzi,Daniele Bissacco,Santi Trimarchi,A. Rodríguez Huerta,Vincent Riambau,Anders Wanhainen
出处
期刊:JAMA Surgery [American Medical Association]
卷期号:158 (8): 832-832 被引量:9
标识
DOI:10.1001/jamasurg.2023.2128
摘要

Importance Endovascular treatment is not recommended for aortic pathologies in patients with connective tissue diseases (CTDs) other than in redo operations and as bridging procedures in emergencies. However, recent developments in endovascular technology may challenge this dogma. Objective To assess the midterm outcomes of endovascular aortic repair in patients with CTD. Design, Setting, and Participants For this descriptive retrospective study, data on demographics, interventions, and short-term and midterm outcomes were collected from 18 aortic centers in Europe, Asia, North America, and New Zealand. Patients with CTD who had undergone endovascular aortic repair from 2005 to 2020 were included. Data were analyzed from December 2021 to November 2022. Exposure All principal endovascular aortic repairs, including redo surgery and complex repairs of the aortic arch and visceral aorta. Main Outcomes and Measures Short-term and midterm survival, rates of secondary procedures, and conversion to open repair. Results In total, 171 patients were included: 142 with Marfan syndrome, 17 with Loeys-Dietz syndrome, and 12 with vascular Ehlers-Danlos syndrome (vEDS). Median (IQR) age was 49.9 years (37.9-59.0), and 107 patients (62.6%) were male. One hundred fifty-two (88.9%) were treated for aortic dissections and 19 (11.1%) for degenerative aneurysms. One hundred thirty-six patients (79.5%) had undergone open aortic surgery before the index endovascular repair. In 74 patients (43.3%), arch and/or visceral branches were included in the repair. Primary technical success was achieved in 168 patients (98.2%), and 30-day mortality was 2.9% (5 patients). Survival at 1 and 5 years was 96.2% and 80.6% for Marfan syndrome, 93.8% and 85.2% for Loeys-Dietz syndrome, and 75.0% and 43.8% for vEDS, respectively. After a median (IQR) follow-up of 4.7 years (1.9-9.2), 91 patients (53.2%) had undergone secondary procedures, of which 14 (8.2%) were open conversions. Conclusions and Relevance This study found that endovascular aortic interventions, including redo procedures and complex repairs of the aortic arch and visceral aorta, in patients with CTD had a high rate of early technical success, low perioperative mortality, and a midterm survival rate comparable with reports of open aortic surgery in patients with CTD. The rate of secondary procedures was high, but few patients required conversion to open repair. Improvements in devices and techniques, as well as ongoing follow-up, may result in endovascular treatment for patients with CTD being included in guideline recommendations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZLP完成签到,获得积分20
1秒前
2秒前
LI发布了新的文献求助30
2秒前
温眸完成签到,获得积分10
3秒前
3秒前
4秒前
坚强三德完成签到 ,获得积分10
5秒前
bkagyin应助luffet采纳,获得10
5秒前
小曹发布了新的文献求助10
5秒前
6秒前
6秒前
Sanqainli发布了新的文献求助10
8秒前
自行者完成签到,获得积分10
8秒前
小北完成签到,获得积分10
10秒前
假面绅士发布了新的文献求助10
12秒前
舒适的易烟完成签到,获得积分10
13秒前
老火发布了新的文献求助10
13秒前
端庄的绯发布了新的文献求助10
14秒前
LI完成签到,获得积分10
14秒前
CodeCraft应助高贵季节采纳,获得10
14秒前
顾矜应助CY采纳,获得10
15秒前
neinei完成签到 ,获得积分10
15秒前
16秒前
科研通AI2S应助假面绅士采纳,获得10
17秒前
科研通AI2S应助假面绅士采纳,获得10
17秒前
大方的板栗完成签到,获得积分10
18秒前
淡然的手套完成签到,获得积分10
18秒前
cuber完成签到 ,获得积分10
18秒前
Jasper应助天啊采纳,获得10
18秒前
19秒前
19秒前
自行者发布了新的文献求助10
20秒前
22秒前
完美世界应助老火采纳,获得10
22秒前
彩虹完成签到,获得积分10
23秒前
xqy发布了新的文献求助10
23秒前
小立发布了新的文献求助10
24秒前
25秒前
烟花应助迅速弘文采纳,获得10
25秒前
26秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
COSMETIC DERMATOLOGY & SKINCARE PRACTICE 388
Case Research: The Case Writing Process 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142138
求助须知:如何正确求助?哪些是违规求助? 2793085
关于积分的说明 7805514
捐赠科研通 2449427
什么是DOI,文献DOI怎么找? 1303274
科研通“疑难数据库(出版商)”最低求助积分说明 626807
版权声明 601291